{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies#webpage",
"url": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies",
"name": "Recognizing the “new normal” of patient-centric clinical studies",
"description": "Explore this Fortrea white paper on recognizing the new normal of patient-centric clinical studies and discover how patient-focused approaches are reshaping modern clinical research, participant engagement, and study participation models across the healthcare industry. The white paper examines the growing importance of patient-centric clinical studies, including strategies to improve patient engagement, reduce participation burden, enhance clinical trial accessibility, and support more flexible and inclusive research experiences for diverse patient populations. Learn how decentralized clinical studies, hybrid participation models, patient retention strategies, diversity and inclusion initiatives, participant-focused study approaches, and more adaptable clinical research models are helping organizations respond to the evolving expectations of modern clinical trials while improving accessibility, strengthening patient experiences, increasing enrollment and retention, and supporting more effective patient-centered clinical development programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Recognizing the “new normal” of patient-centric clinical studies",
"item": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies#webpage"
},
"headline": " New Normal of Patient-Centric Clinical Studies & Participant Engagement Strategies | Fortrea White Paper",
"description": "Explore this Fortrea white paper on recognizing the new normal of patient-centric clinical studies and discover how patient-focused approaches are reshaping modern clinical research, participant engagement, and study participation models across the healthcare industry. The white paper examines the growing importance of patient-centric clinical studies, including strategies to improve patient engagement, reduce participation burden, enhance clinical trial accessibility, and support more flexible and inclusive research experiences for diverse patient populations. Learn how decentralized clinical studies, hybrid participation models, patient retention strategies, diversity and inclusion initiatives, participant-focused study approaches, and more adaptable clinical research models are helping organizations respond to the evolving expectations of modern clinical trials while improving accessibility, strengthening patient experiences, increasing enrollment and retention, and supporting more effective patient-centered clinical development programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-04",
"dateModified": "2025-02-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/recognizing-new-normal-of-patient-centric-clinical-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}